Global Fund Secures Affordable Tuberculosis Test from Cepheid Amid Pressure Campaign

Danaher Corporation has announced an agreement to provide Cepheid's Xpert® MTB/RIF Ultra diagnostic test cartridges for tuberculosis (TB) at cost to the Global Fund to Fight AIDS, TB and Malaria and less-developed countries eligible for Cepheid's Global Access Program. By reducing the price of the test cartridge to $7.97, Danaher will earn no profit. The agreement expands the partnership between Cepheid and the Global Fund, aiming to improve access to high-quality TB testing in countries where it is most needed. The Global Fund is the largest provider of financing and programs to combat TB globally.